ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Warszawa, Mazowieckie, POL:

Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)

adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...

Active, not recruiting
Breast Cancer Stage II
Breast Cancer Stage III
Drug: Palbociclib
Drug: Docetaxel / cyclophosphamide

Phase 2

European Organisation for Research and Treatment of Cancer (EORTC)

Warsaw, Poland and 72 other locations

The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast...

Enrolling
Breast Cancer
Metastatic Breast Cancer
Drug: Elacestrant
Drug: Everolimus

Phase 1, Phase 2

Stemline Therapeutics
Stemline Therapeutics

Warszawa, Mazowieckie, Poland and 116 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 145 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Active, not recruiting
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Warszawa, Mazowieckie, Poland and 317 other locations

in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...

Active, not recruiting
Triple Negative Breast Neoplasms
Drug: Capivasertib
Drug: Trastuzumab deruxtecan

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Warszawa, Poland and 31 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Eribulin
Drug: Vinorelbine

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 166 other locations

(BMs), with previously-treated advanced/metastatic HER2-positive breast cancer whose disease has progressed on prior anti-HER2-base...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab Deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 80 other locations

ribociclib or abemaciclib with letrozole) in people with breast cancer:* HR-positive (breast cancer cells that ne...

Enrolling
Breast Cancer
Drug: PF-07220060
Drug: letrozole

Phase 3

Pfizer
Pfizer

Otwock, Poland and 254 other locations

for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previou...

Enrolling
Metastatic HER2-positive Breast Cancer
Drug: Trastuzumab
Drug: Gemcitabine

Phase 3

Jazz Pharmaceuticals
Jazz Pharmaceuticals

Warszawa, Poland and 143 other locations

of gedatolisib plus fulvestrant and CDK4/6 Inhibitors for the treatment of patients with locally advanced or metastatic HR+/HER2- advanced breast...

Enrolling
Breast Cancer
Drug: Arm A: Gedatolisib + Palbociclib or Ribociclib + Fulvestrant
Drug: Arm B: Palbociclib or Ribociclib + Fulvestrant

Phase 3

Celcuity

Warszawa, Poland and 187 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems